10Y UST5.22%-1.14%30Y MTG7.40%+1.65%SOFR3.87%-0.26%VNQ$89.35+0.74%XLRE$40.85+0.69%FED FUNDS3.88%
Real Estate Trail
Institutional Press Wire
Connect CRE · Capital

Massachusetts Biopharma Sees Capital Resurgence Even as Jobs Post First Annual Decline

Via Connect CRE · August 25, 2026
Compiled by Real Estate Trail Editorial · August 25, 2026

Why this matters

Capital markets activity continues to be defined by the rotation from bank balance sheets to non-bank lenders. Private credit funds have raised record dry powder; banks have tightened CRE underwriting standards for the sixth consecutive quarter. The result is a market where well-sponsored deals clear, and marginal credit pays a meaningful spread to do so. For LPs, the allocation conversation has shifted decisively toward real estate debt, with equity allocations being deployed more selectively into operator-led platforms.

Editorial analysis · Real Estate Trail Editorial

Excerpt from Connect CRE:
Massachusetts’ biopharma industry saw employment shrink by 3.1% in 2025 to 113,503 jobs, the first annual decline in the two decades that industry association MassBio has tracked the sector. Conversely, MassBio’…
Read the full article at Connect CRE →

External link. Real Estate Trail does not republish source content.

Related coverage — Capital